|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/495 | (2006.01) |
| A61P 17/04 | (2006.01) |
| (11) | Number of the document | 2906219 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13774189.8 |
| Date of filing the European patent application | 2013-10-09 | |
| (97) | Date of publication of the European application | 2015-08-19 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-07 |
| (46) | Date of publication of the claims translation | 2019-10-25 |
| (86) | Number | PCT/EP2013/071093 |
| Date | 2013-10-09 |
| (87) | Number | WO 2014/057003 |
| Date | 2014-04-17 |
| (30) | Number | Date | Country code |
| 201261712499 P | 2012-10-11 | US |
| (72) |
EMILIANGELO, Ratti, GB
MICHAEL, Trower, GB
|
| (73) |
NeRRe Therapeutics Limited,
Stevenage Bioscience Catalyst Office F25 Incubator Building Gunnels Wood Road Stevenage Herts, SG1 2FX,
GB
|
| (74) |
Liucija JANICKAITĖ,
Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius,
LT
|
| (54) | Orvepitantas, skirtas lėtinio niežulio gydymui |
| ORVEPITANT FOR THE TREATMENT OF CHRONIC PRURITUS |
| Payment date | Validity (years) | Amount | |
| 2023-10-05 | 11 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-10-09 |